Literature DB >> 12540623

Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function.

Riccardo C Bonadonna1, Michael Stumvoll, Andreas Fritsche, Michele Muggeo, Hans Häring, Enzo Bonora, Timon W van Haeften.   

Abstract

We adapted a minimal model to assess beta-cell function during a hyperglycemic glucose clamp and to uncover peculiar aspects of the relationship among beta-cell function, plasma glucose, and insulin sensitivity (IS) in offspring of Caucasian patients with type 2 diabetes (OfT2D). We pooled two data sets of OfT2D (n = 69) and control subjects (n = 45) with normal glucose regulation. Plasma C-peptide was measured during a hyperglycemic clamp ( approximately 10 mmol/l) to quantify model-based first-phase secretion and glucose sensitivity of second-phase secretion (beta). IS was quantified during the hyperglycemic clamp. In the pooled data, first-phase secretion was linearly and negatively related to fasting plasma glucose, but not IS; OfT2D lay on a distinct line shifted to the left of the control subjects. In contrast, beta was negatively related to IS, and OfT2D lay on a distinct line shifted more and more to the left of the control subjects, as IS was worse. Thus, in OfT2D lower beta-cell adaptive responses exist between ambient glycemia and first-phase insulin secretion and between IS and second-phase secretion. Under conditions leading to decreased insulin sensitivity, these disturbed relationships may lead to progression to diabetes in OfT2D.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540623     DOI: 10.2337/diabetes.52.2.470

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

1.  Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins.

Authors:  M Lehtovirta; J Kaprio; L Groop; M Trombetta; R C Bonadonna
Journal:  Diabetologia       Date:  2005-06-24       Impact factor: 10.122

Review 2.  Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium.

Authors:  Tamara S Hannon; Steven E Kahn; Kristina M Utzschneider; Thomas A Buchanan; Kristen J Nadeau; Philip S Zeitler; David A Ehrmann; Silva A Arslanian; Sonia Caprio; Sharon L Edelstein; Peter J Savage; Kieren J Mather
Journal:  Diabetes Obes Metab       Date:  2017-06-22       Impact factor: 6.577

3.  A family history of type 2 diabetes increases risk factors associated with overfeeding.

Authors:  D Samocha-Bonet; L V Campbell; A Viardot; J Freund; C S Tam; J R Greenfield; L K Heilbronn
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

Review 4.  Clinical pharmacokinetics and pharmacodynamics of vildagliptin.

Authors:  Yan-Ling He
Journal:  Clin Pharmacokinet       Date:  2012-03-01       Impact factor: 6.447

5.  Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.

Authors:  Dorit Samocha-Bonet; Olivia Wong; Emma-Leigh Synnott; Naomi Piyaratna; Ashley Douglas; Fiona M Gribble; Jens J Holst; Donald J Chisholm; Jerry R Greenfield
Journal:  J Nutr       Date:  2011-05-18       Impact factor: 4.798

6.  Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.

Authors:  Ram Weiss; Sylvie Dufour; Sara E Taksali; William V Tamborlane; Kitt F Petersen; Riccardo C Bonadonna; Linda Boselli; Gina Barbetta; Karin Allen; Francis Rife; Mary Savoye; James Dziura; Robert Sherwin; Gerald I Shulman; Sonia Caprio
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

7.  Pharmacokinetics and pharmacodynamics of vildagliptin in patients with type 2 diabetes mellitus.

Authors:  Yan-Ling He; Denise Serra; Yibin Wang; Joelle Campestrini; Gilles-Jacques Riviere; Carolyn F Deacon; Jens J Holst; Sherwyn Schwartz; Jace C Nielsen; Monica Ligueros-Saylan
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts.

Authors:  Fabrice Bonnet; Ronan Roussel; Andrea Natali; Stéphane Cauchi; John Petrie; Martine Laville; Loïc Yengo; Philippe Froguel; Céline Lange; Olivier Lantieri; Michel Marre; Beverley Balkau; Ele Ferrannini
Journal:  Diabetologia       Date:  2013-08-14       Impact factor: 10.122

9.  Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11).

Authors:  C Zusi; E Rinaldi; S Bonetti; M L Boselli; E Trabetti; G Malerba; E Bonora; R C Bonadonna; M Trombetta
Journal:  J Endocrinol Invest       Date:  2021-06-14       Impact factor: 4.256

10.  Impact of triglycerides and waist circumference on insulin resistance and β-cell function in non-diabetic first-degree relatives of type 2 diabetes.

Authors:  Fahd Ahmed; Molham Al-Habori; Ebtesam Al-Zabedi; Riyadh Saif-Ali
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.